BioRestorative Therapies, Inc. (BRTX) stock

BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 8/30

$1.49−0.01 (-0.67%)

Close on Nov 13, 2026Market cap $37.96MP/E –Yield –

BioRestorative Therapies EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

BioRestorative Therapies has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in BioRestorative Therapies's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Sep 8, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BRTX.

Advertisement
300 × 250

See a number that looks wrong?